AZP-3601 SAD and MAD Study in Healthy Subjects and Patients With Hypoparathyroidism

Clinical trial NCT05239221 · COMPLETED

Trial details

NCT number: NCT05239221
Sponsor: Alexion Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Chronic Hypoparathyroidism

Start date: 2020-09-07
Primary completion: 2022-08-23
Enrollment: 132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.